I have previously mentioned in other forum that holders need to be realistic and not to expect a commercial contract before 2024-2025 I was actually optimistic.
With todays update, its safe to say holders should not expect a commercial contract and revenue before 2027-2028 (this is if all going well and no push backs).
I think EMV has a potential but it is at very very very early stages.
GLTAHs
Ann: Stage 2 of Clinical Trial Activated, page-12
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.120(5.41%) |
Mkt cap ! $179.3M | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.17 | $2.07 | $25.34K | 11.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 318 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.22 | 1374 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |